Nurse Practitioner, Family · Bronx, NY
NPI
1295176774
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
2015 Grand Concourse
Bronx, NY, 10453
Phone (718) 583-7736
Groups this clinician bills Medicare through
Medicare paid, 2023
$5,203
105 services
Medicare patients, 2023
79
Average age 70
Drug cost, 2024
$1.5M
7,217 prescriptions
Company payments, 2025
$56.83
From 2 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Pascale Vixama was code 99213 (office e&m - established), 42 times for 42 patients. In total Pascale Vixama billed 105 services in 16 codes, and Medicare paid $5,203.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 42 | 42 | $62.92 | $2,643 |
| 87426 Immunoassay | Office | 14 | 14 | $34.62 | $485 |
| 99442 Telephone Services | Office | 13 | 13 | $60.11 | $781 |
By year: 2022 $5,024 for 58 services; 2023 $5,203 for 105 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 14 | 14 | $34.62 | $485 |
Medicare prescription drug claims, 2024
In 2024, the drug Pascale Vixama prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 897 prescriptions and refills. In total Pascale Vixama wrote 7,217 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 897 | 897 | 344 | $23K |
| Gabapentin Generic | 791 | 819 | 187 | $7,466 |
| Diclofenac Sodium Generic | 747 | 838 | 194 | $441K |
| Ibuprofen Generic | 384 | 396 | 92 | $3,371 |
| Meloxicam Generic | 333 | 356 | 95 | $1,216 |
| Movantik Naloxegol Oxalate | 330 | 347 | 68 | $137K |
| Diclofenac Epolamine Generic | 293 | 314 | 69 | $181K |
| Methocarbamol Generic | 293 | 297 | 97 | $3,271 |
| Naloxone Hcl Generic | 287 | 292 | 95 | $18K |
| Endocet Oxycodone Hcl/Acetaminophen | 243 | 243 | 95 | $5,467 |
| Ztlido Lidocaine | 227 | 234 | 59 | $99K |
| Baclofen Generic | 224 | 229 | 58 | $1,979 |
| Lidocaine Generic | 211 | 220 | 52 | $22K |
| Naproxen-Esomeprazole Mag Naproxen/Esomeprazole Mag | 199 | 235 | 51 | $145K |
| Cyclobenzaprine Hcl Generic | 183 | 186 | 48 | $4,106 |
Brand drugs: 1,425 claims; generic drugs: 5,771 claims; opioid claims: 1,322.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pascale Vixama $56.83 ($56.83 in general payments such as food, travel and fees) from 2 companies. The largest payer was Exact Sciences Corporation with $34.23.
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation EXAS | 1 | $34.23 |
| Forte Bio-Pharma LLC | 1 | $22.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.